Dr John Fitton trained at the University of Birmingham, UK, and has worked in Birmingham, London, and Yorkshire in the UK, and South Africa. He is currently a Rheumatology Research Fellow in Rheumatology at the Leeds Institute of Rheumatic and Musculoskeletal Medicine at the University of Leeds and NIHR Leeds Biomedical Research Centre, UK. His research interests include refractory rheumatoid arthritis and the management of this disease with targeted therapies.
Browse topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA
Anifrolumab for the treatment of SLE
JAK inhibitor safety: Weighing up the data and understanding the risks
Rituximab and rheumatology practice in the COVID-19 era
Safety snapshot: Upadacitinib in patients with PsA
Repurposing rheumatology drugs for COVID-19
Telemedicine in rheumatology: COVID-19 and beyond
Managing PsA in resource-limited settings
Conferences